Home > Analytics > COHANCE LIFESCIENCES

COHANCE LIFESCIENCES
Intrinsic Value | Fundamental Analysis

BOM : 543064     NSE : COHANCE    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
May 22,2026
Price(EOD): ₹ 418.50
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 16,011.81 Cr
Value of ₹ 1 Lac invested in COHANCE LIFESCIENCES
on May 24,2021 (price: ₹ 522.25)

₹ 1 L

₹ 0.80 L

1W : -2.6% 1M : 15.2% 1Y : -60.8%
COMMUNITY POLL
for COHANCE LIFESCIENCES
Please provide your vote to see the results
COHANCE LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
COHANCE LIFESCIENCES -2.6% 15.2% -60.8%
SUN PHARMACEUTICAL INDUSTRIES -3.2% 10.5% 9.3%
DIVIS LABORATORIES 0.8% 9.5% 4.2%
TORRENT PHARMACEUTICALS 2% 9.9% 35.4%
CIPLA -1.9% 13.3% -6%
DR REDDYS LABORATORIES -1.8% 7.4% 8.2%
MANKIND PHARMA -0.6% 11% -1.8%
LUPIN 1.2% -1.2% 12.7%
ZYDUS LIFESCIENCES 4.8% 11.8% 13.7%

FUNDAMENTAL ANALYSIS OF COHANCE LIFESCIENCES

 
Fundamentals Score
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 COHANCE is one of the top 24% companies with good fundamentals ! Discover More →


VALUATION OF COHANCE LIFESCIENCES

 
Valuation Score
[As on : May 22,2026 ]

Ratio Consolidated
P/E
P/B
P/S
106.65
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 150.12 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

4.09
P/B Calculated based on Book Value of Rs 3,911.29 Cr
[Latest Year - Mar2026 - Consolidated Results ]

7.06
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,268.55 Cr
[Latest Qtr - Mar2026 - Consolidated Results ]

Financial Ratios →

Insights 💡 COHANCE is one of the potential top 27% undervalued companies ! Discover More →

FAIR VALUE OF COHANCE LIFESCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
76%
-36%
-35%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF COHANCE LIFESCIENCES


Insights 💡 COHANCE is one of the top 30% companies with bullish price momentum currently! Discover More →

COHANCE LIFESCIENCES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF COHANCE LIFESCIENCES

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0.03
0.02
0.04
0.03
0.05
0.02
0.04
0.04
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF COHANCE LIFESCIENCES

Pledged Promoter Shares
0 %
As on : Mar2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF COHANCE LIFESCIENCES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
13.69%
3.49%
-50.96%
-71.36%
-26.33%
-56.95%
-87.62%
-92.91%
QtrlyTrend
-4
Latest Qtr: Mar2026
Quarterly Result Analysis →


COHANCE LIFESCIENCES related INDICES

BSE Indices1W1M1Y
BSE 400 MIDSMALLCAP INDEX 0.7% 1.2% 3.5%
BSE 1000 0.5% -1.6% -1.3%
BSE 500 0.5% -1.9% -1.5%
BSE HEALTHCARE 0.2% 8.8% 11.4%
BSE 250 SMALLCAP INDEX -0% 1.5% 1.3%
NSE Indices1W1M1Y
NIFTY500 SHARIAH 1% -0.6% -3.1%
NIFTY MIDSMALLCAP 400 0.8% 1.6% 5.5%
NIFTY MNC 0.8% 0.5% 13.5%
NIFTY MIDSMALLCAP400 50:50 0.7% NA NA
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX 0.6% 0.1% 2.1%

You may also like the below Video Courses


FAQ about COHANCE LIFESCIENCES


Is COHANCE LIFESCIENCES good for long term investment?

As on May 22,2026, the Fundamentals of COHANCE LIFESCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of COHANCE LIFESCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is COHANCE LIFESCIENCES UnderValued or OverValued?

As on May 22,2026, COHANCE LIFESCIENCES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of COHANCE LIFESCIENCES ?

As on May 22,2026, the Intrinsic Value of COHANCE LIFESCIENCES is Rs. 644.06 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 237.93
Fair Value [Median EV / Sales Model] : Rs. 651.00
Fair Value [Median Price / Sales Model] : Rs. 644.06
Estimated Median Fair Value of COHANCE LIFESCIENCES : Rs. 644.06

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is COHANCE LIFESCIENCES trading at a Premium or Discount?

As on May 22,2026, COHANCE LIFESCIENCES is trading at a Discount of -35% based on the estimates of Median Intrinsic Value!